| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0167-4889(02)00201-X |
| P698 | PubMed publication ID | 12063175 |
| P2093 | author name string | Yoh Takuwa | |
| Tamio Teramoto | |||
| Yukio Maruyama | |||
| Koichi Sugimoto | |||
| Kenji Nagata | |||
| Keiko Yokoyama | |||
| Toshiyuki Ishibashi | |||
| Hiroshi Ohkawara | |||
| Sotaro Sakurada | |||
| Takayuki Sakamoto | |||
| Joji Shindo | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Posttranslational modification of proteins by isoprenoids in mammalian cells | Q28303329 | ||
| Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase | Q28354356 | ||
| Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3 | Q28582315 | ||
| The coagulation cascade: initiation, maintenance, and regulation | Q28610148 | ||
| Regulation of the mevalonate pathway | Q29547763 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension | Q29614247 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
| A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor | Q30920719 | ||
| The role of Rho in G protein-coupled receptor signal transduction | Q33932175 | ||
| Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. | Q33953572 | ||
| 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase | Q35654989 | ||
| Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries | Q37131350 | ||
| Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis | Q40817145 | ||
| 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins | Q41005307 | ||
| Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy | Q41438612 | ||
| Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes | Q43593692 | ||
| Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression | Q43604739 | ||
| Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury | Q72094659 | ||
| Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study | Q72235431 | ||
| Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study | Q72369100 | ||
| Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo | Q73178265 | ||
| Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study) | Q73289471 | ||
| HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells | Q73435193 | ||
| Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia | Q73630854 | ||
| Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes | Q77199227 | ||
| Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits | Q77367269 | ||
| Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox | Q77756570 | ||
| Are we mortgaging the medical profession? | Q95814757 | ||
| P433 | issue | 1-3 | |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 123-130 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Inhibition of Rho/Rho-kinase signaling downregulates plasminogen activator inhibitor-1 synthesis in cultured human monocytes | |
| P478 | volume | 1590 |
| Q37170931 | Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event |
| Q35200997 | Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes |
| Q40616218 | Increased Expression of Plasminogen Activator Inhibitor-1 by Mediators of the Acute Phase Response: a Potential Progenitor of Vasculopathy in Hypertensives |
| Q42442226 | Intracellular signal transduction modulating expression of plasminogen activator inhibitor-1 in adipocytes |
| Q40387534 | Mechanisms of statin-mediated inhibition of small G-protein function |
| Q37403235 | Pleiotropic vasoprotective effects of statins: the chicken or the egg? |
| Q43699737 | Simvastatin alters fibroblastic cell responses involved in tissue repair |
| Q33882829 | Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes |
| Q36768488 | Statins as first-line therapy for acute coronary syndrome? |
| Q37639928 | Statins for community-acquired pneumonia: current state of the science. |
| Q37276466 | Statins in the first-line therapy of acute coronary syndrome - similar to aspirin? |
| Q46210874 | Statins suppress glucose-induced plasminogen activator inhibitor-1 expression by regulating RhoA and nuclear factor-κB activities in cardiac microvascular endothelial cells |
| Q54589738 | The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin. |
| Q35153749 | The lipid and non-lipid effects of statins |
Search more.